NASA's Curiosity rover can now multitask
These upgrades allow the rover to multitask, performing scientific activities while simultaneously conserving energy from its nuclear battery.
Curiosity can now communicate with an orbiter, drive, move its robotic arm, and capture images concurrently.
The rover can also autonomously decide to power down early if its daily tasks are completed, reducing the need for extensive recharging.
These enhancements aim to maximize the lifespan of its power source, as Curiosity continues to explore Martian geological formations believed to be formed by ancient water.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
28 minutes ago
- Telegraph
US to build nuclear reactor on the moon
The US is planning to build a nuclear reactor on the Moon as it seeks to push ahead in the space race. Sean Duffy, the new Nasa head, is preparing to announce plans to install a small reactor on the moon to allow astronauts to undertake lengthy missions on the lunar surface and pave the way for future Mars expeditions. A directive from the space agency, seen by The Telegraph argues that a reactor is necessary to stop rival superpowers effectively colonising the Moon and establishing US 'keep-out' zones. China and Russia previously announced a joint effort to put a reactor on the Moon by the mid-2030s, it notes. 'The first country to do so could potentially declare a keep-out zone which would significantly inhibit the United States from establishing a planned Artemis presence if not there first,' the directive says, referring to existing plans to explore the Moon and prepare for missions to Mars. Nasa needs to 'move quickly' to 'support a future lunar economy' and 'strengthen our national security in space', it adds. Solar panels are ineffective because nights on the Moon last the equivalent of two weeks on Earth. A Nasa official said: 'If we are going to have a habitable system on the Moon then we have to bring power.' He said small reactors were already in use on submarines and aircraft carriers. 'They solve the problem,' he added. Mr Duffy, who is also the US transport secretary, has directed Nasa to seek industry proposals for a minimum 100 kilowatt reactor to launch by 2030. The agency had already been working on a 40-kilowatt reactor to use on the moon by the early part of the next decade. Mr Duffy was named interim head of Nasa after Donald Trump abruptly withdrew the nomination of Jared Isaacman, a tech billionaire and commercial astronaut. The move deepened a rift between Mr Trump and Elon Musk, the SpaceX billionaire and until that point one of the president's closest political allies. Mr Musk, who had pushed for Mr Isaacman to be named to the top job, wrote on social media in May: 'It is rare to find someone so competent and good hearted'.
Reuters
28 minutes ago
- Reuters
Vertex's trial failure, scrapped study cloud pain drug push; shares slump
Aug 4 (Reuters) - Vertex Pharmaceuticals will stop developing its experimental non-opioid painkiller as a solo treatment after a mid-stage trial failure and will not start a study for expanded use of its approved pain drug, sending its shares down 14.4% after the bell. The company (VRTX.O), opens new tab has been diversifying into gene therapies and non-opioid painkillers as it looks to reduce its reliance on cystic fibrosis drugs, a market it dominates. Unlike opioids, which trigger the brain's reward centers, making them an addiction risk, Vertex's drugs block pain signals at the origin, providing a lucrative opportunity for the company. The next-generation non-opioid painkiller, called VX-993, reduced pain by 74.5 points over 48 hours, compared with 50.2 points in the placebo group, but the difference was not statistically significant, Vertex said. The company tested acute pain reduction in patients who had bunionectomy, a surgery to correct deformed bones of the big toe and foot. The drug was found to be generally safe, with most side effects being mild to moderate and no serious problems linked to the painkiller, the company said. Wall Street analysts and investors have been keenly watching the results of the trial, as Vertex seeks to expand beyond Journavx, its non-opioid approved by the U.S. Food and Drug Administration in January for acute pain. Separately, Vertex also said it would not start a study for Journavx to treat a type of nerve pain in the lower back and legs following discussion with the FDA. Leerink Partners analyst David Risinger said Vertex's pain portfolio updates were "disappointing," despite reporting second-quarter results that were above expectations. Vertex plans to prioritize testing of, and later seeking approval for, Journavx to treat a type of nerve pain in diabetic patients. It will also seek to secure approval for other types of nerve pain, the company said in its earnings press release.
Reuters
an hour ago
- Reuters
UK grants space launch licence to Scottish firm
LONDON, Aug 5 (Reuters) - Britain has granted its first space launch licence to a homegrown rocket company, paving the way for a Scottish start-up to send satellites into space from the country's first vertical launch spaceport. Skyrora, which was founded in 2017, would be able to conduct up to 16 launches a year, subject to further approval by the UK Civil Aviation Authority (CAA), the regulator said on Tuesday. The Scotland-based company would use the SaxaVord Spaceport in the Shetland Islands, northern Scotland, which received a key safety licence last year, meaning rockets could be launched from the site in the future. Germany's Rocket Factory Augsburg was the first company to gain a licence to launch from the site earlier this year. "Granting a home-grown company, Skyrora its launch licence is a major milestone for our space sector and our nation," CAA Chief Executive Rob Bishton said. The space market is forecast to be worth over $1 trillion by 2030 as companies around the world plan to deploy thousands of internet-beaming satellites. Britain has been looking to add launch capabilities to its space industry, which employs over 45,000 people and builds more satellites than anywhere outside the United States. But those efforts were dealt a major blow in early 2023 when a horizontal rocket launch from Newquay, south-west England, failed. A successful vertical launch from SaxaVord would revive the industry's prospects. "Skyrora is proud to be leading efforts that enable launch activity from the UK and we look forward to achieving a reliable commercial launch programme that benefits us all," its Chief Executive Volodymyr Levykin said. The company needs to meet a number of conditions before any launch, including adequate insurance, a data-sharing deal with the British government and airspace agreements with other countries.
